All News

Investigators found genetic evidence that certain sleep behaviors can be risk factors for lifespan.

“I’m better than I was before I had long COVID, and in so many ways,” said a patient in an interview with Pharmacy Times.

The sNDA was based on results from the KRYSTAL-1 study, evaluating the drug alone or in combination with other anti-cancer therapies in those with advanced solid tumors who have KRASG12C mutations.

The withdrawal comes after clinical trial results failed to demonstrate the safety and efficacy of melphalan flufenamide when combined with dexamethasone.

Adalimumab-ryvk is the first high-concentration, citrate-free biosimilar to Humira that has been granted interchangeability status for the 40 mg/0.4 ml injection.

The recommendation comes after positive phase 3 trial results in adult patients with relapsed and refractory multiple myeloma.

A brief overview of 4 recent developments in the treatment of non-small cell lung cancer.

Investigators continue to conduct regulated and controlled clinical trials to build compelling, high-quality evidence on their therapeutic potential.

As of January 2024, Keytruda has been approved for 6 indications in NSCLC across the metastatic and earlier stages of the disease.

In addition to highlighting the difficulties patients face when managing plaque psoriasis and atopic dermatitis, 2 experts describe how pharmacists play a crucial role in treatment.

Four years after congress passed it, the Hannon Act is helping veterans get better care

The question arose whether the court would allow the pharmacist to recover his attorney fees

The evolution of pharmacy, as a practice and profession, is unique in that its evolution has quickened exponentially in just the past 20 years.

The model implemented at City of Hope Chicago has been shown to improve provider workloads and enrich pharmacists’ work.

Dedicated clinical trials in IBD cohorts that scrutinized biosimilar use in real-world clinical practice have direct implications on decision making.

Investing in community relationships and health literacy are key steps pharmacists can take to improve equity.

Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.

Currently, the safety and efficacy of linvoseltamab in adult patients with relapsed or refractory multiple myeloma is being compared to elotuzumab, pomalidomide, and dexamethasone in a phase 3 clinical trial.

These experiences can impact mental health, which can mediate parenting behaviors like inconsistent discipline.

The practice could become routine if parents promote morning vegetable consumption while the children are still in a developmental stage of life.

Its pharmacists and staff combine technology and a personalized touch to care for their community

Patients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.

Precision oncology represents an evolution in therapeutic practice.

Tune into this episode of "Public Health Matters" to learn about the importance of cultural competence when addressing health care disparities and promoting health equity in diverse communities as well as special guest Dr. Jose Cucalon Calderon's advocacy work.

Currently, ocifisertib is being evaluated in a phase 1b and 2 trial to confirm the safety and tolerability profiles in patients with acute myeloid leukemia.

Investigators suggested that this difference is caused by a common medication for treatment-resistant schizophrenia.

Malaria has a large global burden, affecting hundreds of millions of people each year.